RSU-1069

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameRSU-1069

Drug Alias NameRSU-1069

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA damage modulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBtg Plc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBtg Plc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A